West Nile virus
|West Nile virus|
|A micrograph of the West Nile Virus, appearing in yellow|
West Nile virus
West Nile virus (WNV) is a single-stranded RNA virus that causes West Nile fever. It is a member of the family Flaviviridae, specifically from the genus Flavivirus, which also contains the Zika virus, dengue virus, and yellow fever virus. West Nile virus is primarily transmitted by mosquitoes, mostly species of the genus Culex. The primary hosts of WNV are birds, so that the virus remains within a "bird–mosquito–bird" transmission cycle.
Like most other flaviviruses, WNV is an enveloped virus with icosahedral symmetry. Image reconstructions and cryoelectron microscopy reveal a 45–50 nm virion covered with a relatively smooth protein shell; this structure is similar to the dengue fever virus, another Flavivirus. The protein shell is made of two structural proteins: the glycoprotein E and the small membrane protein M. Protein E has numerous functions including receptor binding, viral attachment, and entry into the cell through membrane fusion.
The outer protein shell is covered by a host-derived lipid membrane, the viral envelope. The flavivirus lipid membrane has been found to contain cholesterol and phosphatidylserine, but other elements of the membrane have yet to be identified. The lipid membrane has many roles in viral infection, including acting as signaling molecules and enhancing entry into the cell. Cholesterol, in particular, plays an integral part in WNV entering a host cell. The two viral envelope proteins, E and M, are inserted into the membrane.
The RNA genome is bound to capsid (C) proteins, which are 105 amino-acid residues long, to form the nucleocapsid. The capsid proteins are one of the first proteins created in an infected cell; the capsid protein is a structural protein whose main purpose is to package RNA into the developing viruses. The capsid has been found to prevent apoptosis by affecting the Akt pathway.
WNV is a positive-sense, single-stranded RNA virus. Its genome is approximately 11,000 nucleotides long and is flanked by 5' and 3' non-coding stem loop structures. The coding region of the genome codes for three structural proteins and seven nonstructural (NS) proteins, proteins that are not incorporated into the structure of new viruses. The WNV genome is first translated into a polyprotein and later cleaved by virus and host proteases into separate proteins (i.e. NS1, C, E).
Structural proteins (C, prM/M, E) are capsid, precursor membrane proteins, and envelope proteins, respectively. The structural proteins are located at the 5' end of the genome and are cleaved into mature proteins by proteases.
|C||Capsid protein; encloses the RNA genome, packages RNA into immature virions.|
|prM/M||Viruses with M protein are infectious: the presence of M protein allows for the activation of proteins involved in viral entry into the cell. prM (precursor membrane) protein is present on immature virions, by further cleavage by furin to M protein, the virions become infectious.|
|E||A glycoprotein that forms the viral envelope, binds to receptors on the host cell surface in order to enter the cell.|
Nonstructural proteins consist of NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5. These proteins mainly assist with viral replication or act as proteases. The nonstructural proteins are located near the 3' end of the genome.
|NS1||NS1 is a cofactor for viral replication, specifically for regulation of the replication complex.|
|NS2A||NS2A has a variety of functions: it is involved in viral replication, virion assembly, and inducing host cell death.|
|NS2B||A cofactor for NS3 and together forms the NS2B-NS3 protease complex.|
|NS3||A protease that is responsible for cleaving the polyprotein to produce mature proteins; it can also acts as a helicase.|
|NS4A||NS4A is a cofactor for viral replication, specifically regulates the activity of the NS3 helicase.|
|NS4B||Inhibits interferon signaling.|
|NS5||The largest and most conserved protein of WNV, NS5 acts as a methyltransferase and a RNA polymerase, though it lacks proofreading properties.|
Once WNV has successfully entered the bloodstream of a host animal, the envelope protein, E, binds to attachment factors called glycosaminoglycans on the host cell. These attachment factors aid entry into the cell, however, binding to primary receptors is also necessary. Primary receptors include DC-SIGN, DC-SIGN-R, and the integrin αvβ3. By binding to these primary receptors, WNV enters the cell through clathrin-mediated endocytosis. As a result of endocytosis, WNV enters the cell within an endosome.
The acidity of the endosome catalyzes the fusion of the endosomal and viral membranes, allowing the genome to be released into the cytoplasm. Translation of the positive-sense single-stranded RNA occurs at the endoplasmic reticulum; the RNA is translated into a polyprotein which is then cleaved by viral proteases NS2B-N23 to produce mature proteins.
In order to replicate its DNA, NS5, a RNA polymerase, forms a replication complex with other nonstructural proteins to produce an intermediary negative-sense single-stranded RNA; the negative-sense strand serves as a template for synthesis of the final positive-sense RNA. Once the positive-sense RNA has been synthesized, the capsid protein, C, encloses the RNA strands into immature virions. The rest of the virus is assembled along the endoplasmic reticulum and through the Golgi apparatus, and results in non-infectious immature virions. The E protein is then glycosylated and prM is cleaved by furin, a host cell protease, into the M protein, thereby producing an infectious mature virion. The mature viruses are then secreted out of the cell.
WNV is one of the Japanese encephalitis antigenic serocomplex of viruses, together with Japanese encephalitis virus, Murray Valley encephalitis virus, Saint Louis encephalitis virus and some other flaviruses. Studies of phylogenetic lineages have determined that WNV emerged as a distinct virus around 1000 years ago. This initial virus developed into two distinct lineages. Lineage 1 and its multiple profiles is the source of the epidemic transmission in Africa and throughout the world. Lineage 2 was considered an African zoonosis. However, in 2008, lineage 2, previously only seen in horses in sub-Saharan Africa and Madagascar, began to appear in horses in Europe, where the first known outbreak affected 18 animals in Hungary. Lineage 1 West Nile virus was detected in South Africa in 2010 in a mare and her aborted fetus; previously, only lineage 2 West Nile virus had been detected in horses and humans in South Africa. A 2007 fatal case in a killer whale in Texas broadened the known host range of West Nile virus to include cetaceans.
Since the first North American cases in 1999, the virus has been reported throughout the United States, Canada, Mexico, the Caribbean, and Central America. There have been human cases and equine cases, and many birds are infected. The Barbary macaque, Macaca sylvanus, was the first nonhuman primate to contract WNV. Both the American and Israeli strains are marked by high mortality rates in infected avian populations; the presence of dead birds—especially Corvidae—can be an early indicator of the arrival of the virus.
Host range and transmission
The natural hosts for WNV are birds and mosquitoes. Over 300 different species of bird have been shown to be infected with the virus. Some birds, including the American crow (Corvus brachyrhynchos), blue jay (Cyanocitta cristata) and greater sage-grouse (Centrocercus urophasianus), are killed by the infection, but others survive. The American robin (Turdus migratorius) and house sparrow (Passer domesticus) are thought to be among the most important reservoir species in N. American and European cities. Brown thrashers (Toxostoma rufum), gray catbirds (Dumetella carolinensis), northern cardinals (Cardinalis cardinalis), northern mockingbirds (Mimus polyglottos), wood thrushes (Hylocichla mustelina) and the dove family are among the other common N. American birds in which high levels of antibodies against WNV have been found.
WNV has been demonstrated in a large number of mosquito species, but the most significant for viral transmission are Culex species that feed on birds, including Culex pipiens, C. restuans, C. salinarius, C. quinquefasciatus, C. nigripalpus, C. erraticus and C. tarsalis. Experimental infection has also been demonstrated with soft tick vectors, but is unlikely to be important in natural transmission.
WNV has a broad host range, and is also known to be able to infect at least 30 mammalian species, including humans, some non-human primates, horses, dogs and cats. Some infected humans and horses experience disease but dogs and cats rarely show symptoms. Reptiles and amphibians can also be infected, including some species of crocodiles, alligators, snakes, lizards and frogs. Mammals are considered incidental or dead-end hosts for the virus: they do not usually develop a high enough level of virus in the blood (viremia) to infect another mosquito feeding on them and carry on the transmission cycle; some birds are also dead-end hosts.
In the normal rural or enzootic transmission cycle, the virus alternates between the bird reservoir and the mosquito vector. It can also be transmitted between birds via direct contact, by eating an infected bird carcass or by drinking infected water. Vertical transmission between female and offspring is possible in mosquitoes, and might potentially be important in overwintering. In the urban or spillover cycle, infected mosquitoes that have fed on infected birds transmit the virus to humans. This requires mosquito species that bite both birds and humans, which are termed bridge vectors. The virus can also rarely be spread through blood transfusions, organ transplants, or from mother to baby during pregnancy, delivery, or breastfeeding. Unlike in birds, it does not otherwise spread directly between people.
In humans, West Nile virus can cause a disease known as West Nile fever. According to the U.S. Centers for Disease Control and Prevention, approximately 80% of infected people have few or no symptoms, around 20% of people develop mild symptoms, such as fever, headache, vomiting, or a rash, while less than 1% of people develop severe symptoms, such as encephalitis or meningitis with associated neck stiffness, confusion, or seizures. The risk of death among those in whom the nervous system is affected is about 10%. Recovery may take weeks to months. Risks for severe disease include age over 60 and other health problems. Historically, people in areas where the virus was endemic, such as the Nile Delta, usually experienced subclinical or mild disease. Diagnosis is typically based on symptoms and blood tests. While there is no specific treatment, pain medications may be useful.
There is no human vaccine. The best method to reduce the risk of infections is avoiding mosquito bites. This may be done by eliminating standing pools of water, such as in old tires, buckets, gutters, and swimming pools. Mosquito repellent, window screens, mosquito nets, and avoiding areas where mosquitoes occur may also be useful.
History and epidemiology
West Nile Virus has been reported in Europe, Africa, Asia, Australia, and North America. In the United States thousands of cases are reported a year, with most occurring in August and September. It can occur in outbreaks of disease. A surveillance system in birds is useful for early detection of a potential human outbreak.
- Mackenzie, John S; Gubler, Duane J; Petersen, Lyle R (2004). "Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses". Nature Medicine. 10 (12s): S98–S109. doi:10.1038/nm1144. PMID 15577938.
- Mukhopadhyay, Suchetana; Kim, Bong-Suk; Chipman, Paul R.; Rossmann, Michael G.; Kuhn, Richard J. (2003-10-10). "Structure of West Nile Virus". Science. 302 (5643): 248. doi:10.1126/science.1089316. ISSN 0036-8075. PMID 14551429.
- Kanai, Ryuta; Kar, Kalipada; Anthony, Karen; Gould, L. Hannah; Ledizet, Michel; Fikrig, Erol; Marasco, Wayne A.; Koski, Raymond A.; Modis, Yorgo (2006-11-01). "Crystal Structure of West Nile Virus Envelope Glycoprotein Reveals Viral Surface Epitopes". Journal of Virology. 80 (22): 11000–11008. doi:10.1128/jvi.01735-06. ISSN 0022-538X. PMC 1642136. PMID 16943291.
- Urbanowski, Matt D.; Hobman, Tom C. (2013-01-15). "The West Nile Virus Capsid Protein Blocks Apoptosis through a Phosphatidylinositol 3-Kinase-Dependent Mechanism". Journal of Virology. 87 (2): 872–881. doi:10.1128/jvi.02030-12. ISSN 0022-538X. PMC 3554064. PMID 23115297.
- Meertens, Laurent; Carnec, Xavier; Lecoin, Manuel Perera; Ramdasi, Rasika; Guivel-Benhassine, Florence; Lew, Erin; Lemke, Greg; Schwartz, Olivier; Amara, Ali (2012). "The TIM and TAM Families of Phosphatidylserine Receptors Mediate Dengue Virus Entry". Cell Host & Microbe. 12 (4): 544–557. doi:10.1016/j.chom.2012.08.009. PMC 3572209. PMID 23084921.
- Carro, Ana C.; Damonte, Elsa B. (2013). "Requirement of cholesterol in the viral envelope for dengue virus infection". Virus Research. 174 (1–2): 78–87. doi:10.1016/j.virusres.2013.03.005. PMID 23517753.
- Martín-Acebes, Miguel A.; Merino-Ramos, Teresa; Blázquez, Ana-Belén; Casas, Josefina; Escribano-Romero, Estela; Sobrino, Francisco; Saiz, Juan-Carlos (2014-10-15). "The Composition of West Nile Virus Lipid Envelope Unveils a Role of Sphingolipid Metabolism in Flavivirus Biogenesis". Journal of Virology. 88 (20): 12041–12054. doi:10.1128/jvi.02061-14. ISSN 0022-538X. PMC 4178726. PMID 25122799.
- Medigeshi, Guruprasad R.; Hirsch, Alec J.; Streblow, Daniel N.; Nikolich-Zugich, Janko; Nelson, Jay A. (2008-06-01). "West Nile Virus Entry Requires Cholesterol-Rich Membrane Microdomains and Is Independent of αvβ3 Integrin". Journal of Virology. 82 (11): 5212–5219. doi:10.1128/jvi.00008-08. ISSN 0022-538X. PMC 2395215. PMID 18385233.
- Hunt, Tracey A.; Urbanowski, Matthew D.; Kakani, Kishore; Law, Lok-Man J.; Brinton, Margo A.; Hobman, Tom C. (2007-11-01). "Interactions between the West Nile virus capsid protein and the host cell-encoded phosphatase inhibitor, I2PP2A". Cellular Microbiology. 9 (11): 2756–2766. doi:10.1111/j.1462-5822.2007.01046.x. ISSN 1462-5822. PMID 17868381.
- Guzman, Maria G.; Halstead, Scott B.; Artsob, Harvey; Buchy, Philippe; Farrar, Jeremy; Gubler, Duane J.; Hunsperger, Elizabeth; Kroeger, Axel; Margolis, Harold S. (2010-12-01). "Dengue: a continuing global threat" (PDF). Nature Reviews Microbiology. 8 (12): S7–S16. doi:10.1038/nrmicro2460. ISSN 1740-1534. PMC 4333201. PMID 21079655.
- "Dengue Viruses". www.nature.com. Retrieved 2017-12-19.
- Colpitts, Tonya M.; Conway, Michael J.; Montgomery, Ruth R.; Fikrig, Erol (2012-10-01). "West Nile Virus: Biology, Transmission, and Human Infection". Clinical Microbiology Reviews. 25 (4): 635–648. doi:10.1128/cmr.00045-12. ISSN 0893-8512. PMC 3485754. PMID 23034323.
- Chung, Kyung Min; Liszewski, M. Kathryn; Nybakken, Grant; Davis, Alan E.; Townsend, R. Reid; Fremont, Daved H.; Atkinson, John P.; Diamond, Michael S. (2006-12-12). "West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H". Proceedings of the National Academy of Sciences. 103 (50): 19111–19116. doi:10.1073/pnas.0605668103. ISSN 0027-8424. PMC 1664712. PMID 17132743.
- Londono-Renteria, Berlin; Colpitts, Tonya M. (2016). A Brief Review of West Nile Virus Biology. Methods in Molecular Biology. 1435. pp. 1–13. doi:10.1007/978-1-4939-3670-0_1. ISBN 978-1-4939-3668-7. ISSN 1940-6029. PMID 27188545.
- Moesker, Bastiaan; Rodenhuis-Zybert, Izabela A.; Meijerhof, Tjarko; Wilschut, Jan; Smit, Jolanda M. (2010). "Characterization of the functional requirements of West Nile virus membrane fusion". Journal of General Virology. 91 (2): 389–393. doi:10.1099/vir.0.015255-0. PMID 19828760.
- Perera-Lecoin, Manuel; Meertens, Laurent; Carnec, Xavier; Amara, Ali (2013-12-30). "Flavivirus Entry Receptors: An Update". Viruses. 6 (1): 69–88. doi:10.3390/v6010069. PMC 3917432. PMID 24381034.
- Youn, Soonjeon; Ambrose, Rebecca L.; Mackenzie, Jason M.; Diamond, Michael S. (2013-11-18). "Non-structural protein-1 is required for West Nile virus replication complex formation and viral RNA synthesis". Virology Journal. 10: 339. doi:10.1186/1743-422x-10-339. ISSN 1743-422X. PMC 3842638. PMID 24245822.
- Melian, Ezequiel Balmori; Edmonds, Judith H.; Nagasaki, Tomoko Kim; Hinzman, Edward; Floden, Nadia; Khromykh, Alexander A. (2013). "West Nile virus NS2A protein facilitates virus-induced apoptosis independently of interferon response". Journal of General Virology. 94 (2): 308–313. doi:10.1099/vir.0.047076-0. PMC 3709616. PMID 23114626.
- Shiryaev, Sergey A.; Chernov, Andrei V.; Aleshin, Alexander E.; Shiryaeva, Tatiana N.; Strongin, Alex Y. (2009). "NS4A regulates the ATPase activity of the NS3 helicase: a novel cofactor role of the non-structural protein NS4A from West Nile virus". Journal of General Virology. 90 (9): 2081–2085. doi:10.1099/vir.0.012864-0. PMC 2887571. PMID 19474250.
- Wicker, Jason A.; Whiteman, Melissa C.; Beasley, David W.C.; Davis, C. Todd; McGee, Charles E.; Lee, J. Ching; Higgs, Stephen; Kinney, Richard M.; Huang, Claire Y.-H. (2012). "Mutational analysis of the West Nile virus NS4B protein". Virology. 426 (1): 22–33. doi:10.1016/j.virol.2011.11.022. PMC 4583194. PMID 22314017.
- Davidson, Andrew D. (2009). Chapter 2 New Insights into Flavivirus Nonstructural Protein 5. Advances in Virus Research. 74. pp. 41–101. doi:10.1016/s0065-3527(09)74002-3. ISBN 9780123785879. PMID 19698895.
- Brinton, Margo A. (2002-10-01). "The Molecular Biology of West Nile Virus: A New Invader of the Western Hemisphere". Annual Review of Microbiology. 56 (1): 371–402. doi:10.1146/annurev.micro.56.012302.160654. ISSN 0066-4227. PMID 12142476.
- Samuel, Melanie A.; Diamond, Michael S. (2006-10-01). "Pathogenesis of West Nile Virus Infection: a Balance between Virulence, Innate and Adaptive Immunity, and Viral Evasion". Journal of Virology. 80 (19): 9349–9360. doi:10.1128/jvi.01122-06. ISSN 0022-538X. PMC 1617273. PMID 16973541.
- Vancini, Ricardo; Kramer, Laura D.; Ribeiro, Mariana; Hernandez, Raquel; Brown, Dennis (2013). "Flavivirus infection from mosquitoes in vitro reveals cell entry at the plasma membrane". Virology. 435 (2): 406–414. doi:10.1016/j.virol.2012.10.013. PMID 23099205.
- Mukhopadhyay, Suchetana; Kuhn, Richard J.; Rossmann, Michael G. (2005). "A structural perspective of the flavivirus life cycle". Nature Reviews Microbiology. 3 (1): 13–22. doi:10.1038/nrmicro1067. PMID 15608696.
- Suthar, Mehul S.; Diamond, Michael S.; Jr, Michael Gale (2013). "West Nile virus infection and immunity". Nature Reviews Microbiology. 11 (2): 115–128. doi:10.1038/nrmicro2950. PMID 23321534.
- Lanciotti RS, Ebel GD, Deubel V, et al. (June 2002). "Complete genome sequences and phylogenetic analysis of West Nile virus strains isolated from the United States, Europe, and the Middle East". Virology. 298 (1): 96–105. doi:10.1006/viro.2002.1449. PMID 12093177.
- Lobigs M, Diamond MS (2012). "Feasibility of cross-protective vaccination against flaviviruses of the Japanese encephalitis serocomplex". Expert Rev Vaccines. 11 (2): 177–87. doi:10.1586/erv.11.180. PMC 3337329. PMID 22309667.
- Galli M, Bernini F, Zehender G (July 2004). "Alexander the Great and West Nile virus encephalitis". Emerging Infect. Dis. 10 (7): 1330–2, author reply 1332–3. doi:10.3201/eid1007.040396. PMID 15338540.
- West, Christy (2010-02-08). "Different West Nile Virus Genetic Lineage Evolving?". The Horse. Archived from the original on 2010-02-17. Retrieved 2010-02-10. From statements by Orsolya Kutasi, DVM, of the Szent Istvan University, Hungary at the 2009 American Association of Equine Practitioners Convention, December 5–9, 2009.
- Venter M, Human S, van Niekerk S, Williams J, van Eeden C, Freeman F (August 2011). "Fatal neurologic disease and abortion in mare infected with lineage 1 West Nile virus, South Africa". Emerging Infect. Dis. 17 (8): 1534–6. doi:10.3201/eid1708.101794. PMC 3381566. PMID 21801644.
- St Leger J, Wu G, Anderson M, Dalton L, Nilson E, Wang D (2011). "West Nile virus infection in killer whale, Texas, USA, 2007". Emerging Infect. Dis. 17 (8): 1531–3. doi:10.3201/eid1708.101979. PMC 3381582. PMID 21801643.
- Hogan, C. Michael (2008). Barbary Macaque: Macaca sylvanus, GlobalTwitcher.com Archived 2009-08-31 at the Wayback Machine
- "West Nile virus". World Health Organization. 3 October 2017. Retrieved 28 March 2019.
- "Vertebrate Ecology". West Nile Virus. Division of Vector-Borne Diseases, CDC. 30 April 2009. Archived from the original on 1 March 2013.
- "Species of dead birds in which West Nile virus has been detected, United States, 1999–2016" (PDF). CDC. Retrieved 28 March 2019.
- Kilpatrick, AM; SL LaDeau; PP Marra (2007). "Ecology of West Nile virus transmission and its impact on birds in the western hemisphere". The Auk. 124 (4): 1121–36. doi:10.1642/0004-8038(2007)124[1121:EOWNVT]2.0.CO;2.
- Kaci K. VanDalen; Jeffrey S. Hall; Larry Clark; Robert G. McLean; Cynthia Smeraski (2013). "West Nile Virus Infection in American Robins: New Insights on Dose Response". PLoS One. 8: e68537. doi:10.1371/journal.pone.0068537. PMID 23844218.
- Kilpatrick, AM; P Daszak; MJ Jones; PP Marra; LD Kramer (2006). "Host heterogeneity dominates West Nile virus transmission". Proceedings of the Royal Society B: Biological Sciences. 273 (1599): 2327–2333. doi:10.1098/rspb.2006.3575. PMC 1636093. PMID 16928635.
- Virginia Gamino; Ursula Höfle (2013). "Pathology and tissue tropism of natural West Nile virus infection in birds: a review". Veterinary Research. 44: 39. doi:10.1186/1297-9716-44-39.
- Lawrie, Charles; Uzcátegui, Nathalie; Gould, Ernest; Nuttall, Patricia (April 2004). "Ixodid and Argasid Tick Species and West Nile Virus". Emerging Infectious Diseases. 10 (4): 653–657. doi:10.3201/eid1004.030517. PMC 3323096. PMID 15200855.
- Marion S. Ratterree; Amelia P.A. Travassos da Rosa; Rudolf P. Bohm, Jr; et al. (2003). "West Nile Virus Infection in Nonhuman Primate Breeding Colony, Concurrent with Human Epidemic, Southern Louisiana" (PDF). Emerging Infectious Diseases. 9: 1388–94.
- Peter P. Marra; Sean Griffing; Carolee Caffrey; et al. (2004). "West Nile Virus and Wildlife". BioScience. 54: 393–402. doi:10.1641/0006-3568(2004)054[0393:WNVAW]2.0.CO;2.
- Amir Steinman; Caroline Banet-Noach; Shlomit Tal; et al. (2003). "West Nile Virus Infection in Crocodiles". Emerging Infectious Diseases. 9: 887–89. doi:10.3201/eid0907.020816. PMID 12899140.
- C. R. Dahlina; D. F. Hughes; W. E. Meshaka, Jr; C. Coleman; J. D. Henning (2016). "Wild snakes harbor West Nile virus". One Health. 2: 136–38. doi:10.1016/j.onehlt.2016.09.003.
- Ellen Ariel (2011). "Viruses in reptiles". Veterinary Research. 42: 100. doi:10.1186/1297-9716-42-100.
- Goddard LB, Roth AE, Reisen WK, Scott TW (November 2003). "Vertical transmission of West Nile Virus by three California Culex (Diptera: Culicidae) species". J. Med. Entomol. 40 (6): 743–6. doi:10.1603/0022-2585-40.6.743. PMID 14765647.
- Bugbee, LM; Forte LR (September 2004). "The discovery of West Nile virus in overwintering Culex pipiens (Diptera: Culicidae) mosquitoes in Lehigh County, Pennsylvania". Journal of the American Mosquito Control Association. 20 (3): 326–7. PMID 15532939.
- "General Questions About West Nile Virus". www.cdc.gov. 19 October 2017. Archived from the original on 26 October 2017. Retrieved 26 October 2017.
- Scott C. Weaver, Caroline Charlier, Nikos Vasilakis, Marc Lecuit (2018). "Zika, Chikungunya, and Other Emerging Vector-Borne Viral Diseases". Annual Review of Medicine. 69: 395–408. doi:10.1146/annurev-med-050715-105122.CS1 maint: Uses authors parameter (link)
- "West Nile virus". World Health Organization. July 2011. Archived from the original on 18 October 2017. Retrieved 28 October 2017.
- "Symptoms, Diagnosis, & Treatment". www.cdc.gov. 15 January 2019. Archived from the original on 15 January 2019. Retrieved 15 January 2019.
- "Final Cumulative Maps and Data | West Nile Virus | CDC". www.cdc.gov. 24 October 2017. Archived from the original on 27 October 2017. Retrieved 28 October 2017.
|Scholia has a topic profile for West Nile virus.|